SARA WELCH: Open Payments
NPI 1861689606 · DAPHNE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,543 in 70 payments from 18 companies in 2025. Trend: 2023 $2,391 · 2024 $1,475 · 2025 $1,543
Food & beverage: $1,543
| Company | Payments | Amount |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 13 | $308 |
| Axsome Therapeutics, Inc. | 10 | $263 |
| HARMONY BIOSCIENCES LLC | 11 | $148 |
| Regeneron Healthcare Solutions, Inc. | 5 | $114 |
| Regeneron Pharmaceuticals, Inc. | 1 | $107 |
| Novo Nordisk Inc | 5 | $102 |
| Lilly USA, LLC | 3 | $66 |
| Novartis Pharmaceuticals Corporation | 3 | $63 |
| Esperion Therapeutics, Inc. | 3 | $58 |
| Abbott Laboratories | 3 | $50 |
Products named: XYWAV, Sunosi, EVKEEZA, WAKIX, Wegovy, LEQVIO, NEXLETOL, FREESTYLE LIBRE 3.
Industry payments across AL — which companies pay providers there.
